Possibilities of the ReLEx® SMILE technology in patients aged 16–17 years

    Abstract

    Possibilities of the ReLEx® SMILE technology in patients aged 16–17 years

    A.B. Kachanov , S.A. Nikulin , E.V. Boiko

    The S. Fyodorov Eye Microsurgery Federal State Institution, the St.-Petersburg ranch
The I.I. Mechnikov North-Western State Medical University of the Ministry of Health of Russia, St. Petersburg

    Purpose. To study the use of ReLEx®SMILE operation for the correction of myopia and myopic astigmatism in patients aged 16-17 years.

    Material and methods. The ReLEx® SMILE operation was performed in 36 eyes of 18 patients, 12 boys (66.7%) of them and 6 girls (33.3%) using the “VISUMAX” femtosecond laser platform (“Carl Zeiss Meditec”) to correct myopia and myopic astigmatism. The follow-up period was 6 months.

    Results. The day after the ReLEx®SMILE the anterior segment of the eye looked calm and intact in all patients, the uncorrected visual acuity (UCVA) increased from 0.09± 0.06 to 1.10± 0.16 postoperatively 6 months later (p <0.001). The efficacy and safety indices at the end of the follow-up period were above 1.0.

    Conclusion. The ReLEx®SMILE technology is a promising and modern method to correct myopia in patients starting aged 16–17 years, with a rapid recovery of UCVA and the absence of a superficial corneal flap.

    Key words: femtosecond laser, VISUMAX, ReLEx® SMILE, lenticula, patients of 16-17 years old, myopia, incision, loss of vacuum.